Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Silverman who wrote (160)	1/17/1997 1:52:00 AM
From: scaram(o)uche	of 6136

Bingo. There have been some classic bails (Immunomedics, Cytel among many others) in biotech, but AGPH is on the opposite end of the spectrum. If AGPH insiders sell a reasonable percentage of their shares into this rally, I'll be celebrating their patience. OK, we're going to take another hit on the issues of this past week.... that the Vertex molecule is dosed 2X/day rather than 3X/day, and that Viracept has a side-effect of diahhrea versus zip for Vertex. My response to that? Vertex is just now entering phase III trials. FDA might not love Vertex for advertising zero side effects before entering phase III testing. In the old days, companies showed more respect for the FDA and the approval process. Apart from that, Vertex/Glaxo seem to be missing one important point...... they're behind. In the next breath let me say that I also really like Vertex as an investment. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next